HIPAA Alert: Potential Data Breach Learn More
Questions on Oncology, Hematology and/or Infusion Clinical Services due to COVID-19 Crisis – CALL 833-698-1623
Important Information for Our Patients Regarding the Coronavirus.
RCCA Providing Area Cancer Patients with Access to Care During Coronavirus Outbreak
RCCA Offering Patients Virtual Visits During Coronavirus Pandemic
Board Certifications: Hematology, Internal Medicine and Medical Oncology
Languages: English and Spanish
Locations: Riverdale, NJ
Call Riverdale, NJ: (973) 831-5451
Vinod Varki, MD, specializes in hematology, internal medicine, and medical oncology, with a special focus on lung cancer, breast cancer, and gastrointestinal malignancies. He serves patients at Regional Cancer Care Associates (RCCA) in Riverdale, New Jersey, with a variety of cutting-edge treatments. He has special expertise with infusion therapy, subcutaneous injections, and oral drugs.
Dr. Varki specializes in General Hematology Oncology. He works with a wide variety of cancer types, with a particular interest in lung cancer, breast cancer, and gastrointestinal (GI) malignancies. No two cases of cancer are alike, which is why he employs a variety of treatment types to help patients achieve the best possible outcomes. He has expertise in:
More importantly, he understands that a cancer diagnosis can be frightening. “It’s a new language for the patient,” he says. “I try to serve as a guide and a cheerleader for them.” He takes the time to answer questions and explain foreign concepts, helping patients understand their diagnosis, treatment options, and prognosis. This helps ease anxieties as patients get ready for treatment. Patients know that he is on their side through a difficult journey.
Dr. Varki is a member of American Society of Clinical Oncology (ASCO), the world’s leading professional organization for oncology professionals. Through his membership, Dr. Varki can share knowledge with thousands of other physicians and researchers. This helps him stay current with the latest breakthroughs in cancer treatment and empowers him to deliver a higher level of care.
Medical school: Vanderbilt University School of Medicine, 2011
Internship: University of Rochester Medical Center, 2012
Residency: University of Rochester Medical Center, 2014
Fellowship: University of Maryland Medical Center, 2017
Board certifications: Hematology, Internal Medicine, and Medical Oncology
Dr. Varki’s mother is a medical oncologist. After witnessing her outstanding work, he became determined to follow in her footsteps. He remains in the field, however, for the close and deep connections he develops with patients.
“The most satisfying thing about being a medical oncologist,” says Dr. Varki, “is that there are many different treatment types out there to treat all different types of tumors.” He is constantly inspired by the advances being made, including:
To Dr. Varki, this ever-changing landscape is intellectually challenging and fulfilling. “It is also emotionally satisfying to see success stories for my cancer patients,” he adds, especially for cancers that were difficult or impossible to cure beforehand.
When patients come to Dr. Varki with a cancer diagnosis, his first focus is on transition. Hematological and oncological care is complex and often overwhelming. “Regardless of the stage and outcome,” Dr. Varki says, “there will always be a plan.” He works with the patient to help them understand their options and the nuances of treatment, ensuring that their transition is as smooth as possible.
Patients in need of care may schedule a consultation with Dr. Varki in Riverdale, NJ.
Phone:
Fax:
He also has hospital affiliations at Chilton Medical Center, Overlook Medical Center, and Morristown Medical Center, which are all part of the Atlantic Health System.
For more information or to schedule an appointment, call 844-346-7222. You can also schedule an appointment by calling the RCCA location nearest you.
Regional Cancer Care Associates is one of fewer than 200 medical practices in the country selected to participate in the Oncology Care Model (OCM); a recent Medicare initiative aimed at improving care coordination and access to and quality of care for Medicare beneficiaries undergoing chemotherapy treatment.